NCT07469319 2026-03-13
BISHOP
University of Aarhus
Phase NA Recruiting
Clinical Trials
20 trialsNCT05095714 2026-03-12
FASTRAK
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT06096779 2026-03-06
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT07010315 2026-03-04
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Recruiting
NCT04485286 2026-02-27
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Massachusetts General Hospital
Phase 2 Recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT06912763 2026-01-26
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT05486572 2025-09-26
PREMIUM
VA Office of Research and Development
Phase NA Recruiting
NCT06265272 2025-09-26
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Massachusetts General Hospital
Recruiting
NCT05971108 2025-09-24
REVISE-HCC
Manchester University NHS Foundation Trust
Phase NA Recruiting
NCT06658782 2025-09-22
AMULET
University of Oxford
Recruiting
NCT07132515 2025-08-20
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
Phase 4 Recruiting
NCT06125743 2025-08-14
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Abramson Cancer Center at Penn Medicine
Phase NA Recruiting
NCT05433467 2025-08-13
CTMH
Northern Jiangsu People's Hospital
Phase NA Recruiting
NCT05463796 2025-08-07
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
Recruiting
NCT07079150 2025-07-22
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
Recruiting
NCT07036874 2025-06-29
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Chinese University of Hong Kong
Recruiting
NCT05339984 2025-06-27
LSM
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting